Bumi Resources Minerals Tbk vs Merck Tbk. — how do they compare? Bumi Resources Minerals Tbk trades at Rp565 (market cap 78.69T, 269.76M 24h volume), while Merck Tbk. trades at Rp3,860 (market cap 1.7T, 34.1K 24h volume). The key difference: Bumi Resources Minerals Tbk is far larger — about 46.3× Merck Tbk.'s market cap, and Bumi Resources Minerals Tbk is more actively traded (269.76M versus 34.1K). Which is the better fit depends on your goals.
| BRMS | MERK | |
|---|---|---|
Market Cap | 78.69T | 1.7T |
Volume | 269.76M | 34.1K |
Lot | 2.7M | 341 |
Turnover | 152.55B | 131.02M |
Average Price | 565.52 | 3,842.14 |
Value | 152.55B | 131.02M |
Indicative Equilibrium Price | 560 | 3,850 |
Indicative Equilibrium Volume | 26.16K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bumi Resources Mineral (the company) was established under its original name of PT Panorama Timur Abadi base on notarial deed No.3 of Mr Safrudin, S.H, dated on 6 Aug, 2003. The Company’s articles of association has been amended several times, most recently by notarial deed No.102 of Humberg Lie, S.H., dated Jun 22, 2010, concerning among others, change the name of the company the composition of the Board of Directors and Commissioners, and public offering.
Read more on BRMS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →